BDSX (Biodesix) EV-to-EBIT : -2.71 (As of Jul. 13, 2025)

Biodesix EV-to-EBIT Chart

Biodesix Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															-5.05	-6.84	-8.27	-7.45	-4.13

Competitive Comparison of Biodesix's EV-to-EBIT

For the Diagnostics & Research subindustry, Biodesix's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biodesix's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biodesix's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biodesix's EV-to-EBIT falls into.

Biodesix EV-to-EBIT Calculation

Biodesix's EV-to-EBIT for today is calculated as:

Biodesix's current Enterprise Value is $89.44 Mil.
Biodesix's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-33.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodesix  (NAS:BDSX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biodesix's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Biodesix's Enterprise Value for the quarter that ended in Mar. 2025 was $136.24 Mil.
Biodesix's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-33.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodesix EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biodesix's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biodesix Business Description